Log in

NYSE:CHEChemed Stock Price, Forecast & News

+6.00 (+1.19 %)
(As of 08/13/2020 04:00 PM ET)
Today's Range
Now: $509.00
50-Day Range
MA: $477.05
52-Week Range
Now: $509.00
Volume48,500 shs
Average Volume108,605 shs
Market Capitalization$8.10 billion
P/E Ratio31.99
Dividend Yield0.25%
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio.
Read More
Chemed logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.75 out of 5 stars

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services



Sales & Book Value

Annual Sales$1.94 billion
Cash Flow$17.14 per share
Book Value$45.39 per share


Net Income$219.92 million


Market Cap$8.10 billion
Next Earnings Date11/3/2020 (Estimated)
+6.00 (+1.19 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Chemed (NYSE:CHE) Frequently Asked Questions

How has Chemed's stock been impacted by Coronavirus (COVID-19)?

Chemed's stock was trading at $414.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CHE shares have increased by 22.9% and is now trading at $509.00.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Chemed?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Chemed

When is Chemed's next earnings date?

Chemed is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Chemed

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) released its earnings results on Wednesday, July, 29th. The company reported $4.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.75 by $0.66. The business had revenue of $502.20 million for the quarter, compared to the consensus estimate of $522.90 million. Chemed had a return on equity of 36.71% and a net margin of 12.99%. The business's revenue for the quarter was up 6.0% on a year-over-year basis. During the same period last year, the company earned $3.36 EPS.
View Chemed's earnings history

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Thursday, August 6th. Stockholders of record on Monday, August 17th will be paid a dividend of $0.34 per share on Friday, September 4th. This represents a $1.36 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date of this dividend is Friday, August 14th. This is a positive change from Chemed's previous quarterly dividend of $0.32.
View Chemed's dividend history

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY20 earnings guidance on Wednesday, July, 29th. The company provided EPS guidance of $16.20-16.40 for the period, compared to the Thomson Reuters consensus estimate of $16.13.

What price target have analysts set for CHE?

4 brokers have issued 1-year target prices for Chemed's stock. Their forecasts range from $490.00 to $535.00. On average, they expect Chemed's stock price to reach $515.00 in the next year. This suggests a possible upside of 1.2% from the stock's current price.
View analysts' price targets for Chemed

Has Chemed been receiving favorable news coverage?

Headlines about CHE stock have trended negative on Friday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemed earned a daily sentiment score of -2.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about Chemed

Are investors shorting Chemed?

Chemed saw a decline in short interest in June. As of June 15th, there was short interest totaling 197,500 shares, a decline of 25.4% from the May 31st total of 264,900 shares. Based on an average daily trading volume, of 119,000 shares, the days-to-cover ratio is currently 1.7 days. Approximately 1.3% of the company's shares are sold short.
View Chemed's Short Interest

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), AbbVie (ABBV), Home Depot (HD), CVS Health (CVS), Verizon Communications (VZ), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Chevron (CVX) and Gilead Sciences (GILD).

Who are Chemed's key executives?

Chemed's management team includes the following people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by many different institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (2.12%), FMR LLC (2.11%), Bank of New York Mellon Corp (1.26%), Fisher Asset Management LLC (1.14%), TimesSquare Capital Management LLC (1.14%) and Teacher Retirement System of Texas (1.13%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs.
View institutional ownership trends for Chemed

Which major investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, FMR LLC, Boston Trust Walden Corp, Riverbridge Partners LLC, Fort Washington Investment Advisors Inc. OH, Gamco Investors INC. ET AL, First Trust Advisors LP, and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, Donald E Saunders, Frank E Wood, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Patrick P Grace, Spencer S Lee, and Walter L Krebs.
View insider buying and selling activity for Chemed

Which major investors are buying Chemed stock?

CHE stock was acquired by a variety of institutional investors in the last quarter, including Trinity Street Asset Management LLP, Marshall Wace North America L.P., Teacher Retirement System of Texas, Hudson Bay Capital Management LP, Raymond James & Associates, Nordea Investment Management AB, Princeton Portfolio Strategies Group LLC, and Contravisory Investment Management Inc..
View insider buying and selling activity for Chemed

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $509.00.

How big of a company is Chemed?

Chemed has a market capitalization of $8.10 billion and generates $1.94 billion in revenue each year. The company earns $219.92 million in net income (profit) each year or $13.95 on an earnings per share basis. Chemed employs 16,641 workers across the globe.

What is Chemed's official website?

The official website for Chemed is www.chemed.com.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.